Apple expected to add up to $100 billion to buyback program while many companies halt repurchases

2020-04-23T15:50:28-07:00

Published: April 22, 2020 at 3:08 p.m. ET By Emily Bary Analyst says it’s ‘a logical decision given how attractive the current stock price is Referenced Symbols At a time when ...

Apple expected to add up to $100 billion to buyback program while many companies halt repurchases2020-04-23T15:50:28-07:00

Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment

2020-04-16T16:24:55-07:00

By ADAM FEUERSTEIN @adamfeuerstein and MATTHEW HERPER @matthewherper APRIL 16, 2020 A vial of the remdesivir, an investigational drug from Gilead.GILEAD SCIENCES VIA AP AChicago hospital treating severe Covid-19 patients with Gilead Sciences’ antiviral medicine remdesivir in a ...

Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment2020-04-16T16:24:55-07:00

Stocks will revisit their coronavirus crash low, and here’s when to expect it

2020-04-11T16:43:01-07:00

Published: April 11, 2020 at 4:26 p.m. ET By Mark Hulbert U.S. market history points to a final bottom in August Is the great coronavirus bear market of 2020 now history? ...

Stocks will revisit their coronavirus crash low, and here’s when to expect it2020-04-11T16:43:01-07:00

16 million people just got laid off but U.S. stocks had their best week in 45 years

2020-04-11T16:35:10-07:00

Published: April 11, 2020 at 3:49 p.m. ET By Andrea Riquier Don’t fight the Fed. Referenced Symbols DJIA +1.22%  SPX +1.44%  COMP +0.77%    This was the best of weeks, and ...

16 million people just got laid off but U.S. stocks had their best week in 45 years2020-04-11T16:35:10-07:00

Second Potential COVID-19 Vaccine, Backed By Bill Gates, Enters Human Testing

2020-04-08T15:58:55-07:00

By  Joseph Curl DailyWire.com A second potential COVID-19 vaccine has entered Phase 1 clinical human testing after the U.S. Food and Drug Administration (FDA) accepted an application from Inovio Pharmaceuticals. “Inovio ...

Second Potential COVID-19 Vaccine, Backed By Bill Gates, Enters Human Testing2020-04-08T15:58:55-07:00

GTI Q4 Revenue Grows 265% to $75.8 Million

2020-03-30T17:16:23-07:00

Green Thumb Industries (GTI) Announces Fourth Quarter Revenue of $75.8 Million and Fourth Quarter Adjusted Operating EBITDA of $14.4 Million Full year revenue of $216.4 million Delivers on new store ...

GTI Q4 Revenue Grows 265% to $75.8 Million2020-03-30T17:16:23-07:00

Cannabis sales hit new highs in US and Canada

2020-03-25T15:36:17-07:00

Cannabis sales are touching new highs as customers across the US and Canada stockpile weed to prepare for long spells of isolation because of the coronavirus pandemic. Between March 16 and ...

Cannabis sales hit new highs in US and Canada2020-03-25T15:36:17-07:00

Adaptive Ad Systems Bullish on Television Advertising Market

2020-03-16T20:03:06-07:00

Continues Deployment of its proprietary Ad Technology with new Installations March 17, 2020.  Adaptive Ad Systems, Inc. (OTC: AATV). announced today that it remains bullish on the television advertising market ...

Adaptive Ad Systems Bullish on Television Advertising Market2020-03-16T20:03:06-07:00

Tilray, Inc. Announces Pricing of its $90.4 Million Registered Offering

2020-03-13T14:18:31-07:00

March 13, 2020 09:10 AM Eastern Daylight Time NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced ...

Tilray, Inc. Announces Pricing of its $90.4 Million Registered Offering2020-03-13T14:18:31-07:00

STOCKWATCHINDEX © 2023 | ALL RIGHTS RESERVED | LEGAL | TERMS OF USE | PRIVACY POLICY

Go to Top